Colgate-Palmolive Company (CL)
NYSE: CL · Real-Time Price · USD
90.20
-0.67 (-0.74%)
Aug 20, 2026, 2:20 PM EDT - Market open
Colgate-Palmolive Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,047 | 20,382 | 20,101 | 19,457 | 17,967 | 17,421 | |
Revenue Growth | 5.25% | 1.40% | 3.31% | 8.29% | 3.13% | 5.77% |
Cost of Revenue | 8,328 | 8,131 | 7,920 | 8,131 | 7,719 | 7,046 |
Gross Profit | 12,719 | 12,251 | 12,181 | 11,326 | 10,248 | 10,375 |
Selling, General & Admin | 8,231 | 7,887 | 7,810 | 7,244 | 6,645 | 6,477 |
Other Operating Expenses | 147 | 126 | 121 | 148 | 41 | 85 |
Operating Expenses | 8,378 | 8,013 | 7,931 | 7,392 | 6,686 | 6,562 |
Operating Income | 4,341 | 4,238 | 4,250 | 3,934 | 3,562 | 3,813 |
Interest Expense | -254 | -267 | -292 | -287 | -167 | -117 |
Interest & Investment Income | 73 | 75 | 67 | 55 | 14 | 17 |
Earnings From Equity Investments | 20 | 20 | 22 | 17 | 12 | 12 |
EBT Excluding Unusual Items | 4,180 | 4,066 | 4,047 | 3,719 | 3,421 | 3,725 |
Merger & Restructuring Charges | -318 | -22 | -85 | -24 | -109 | - |
Impairment of Goodwill | -582 | -582 | - | - | -721 | - |
Gain (Loss) on Sale of Investments | -1 | -1 | -6 | -11 | 22 | 8 |
Gain (Loss) on Sale of Assets | - | - | - | - | 47 | - |
Asset Writedown | -337 | -337 | - | - | - | -571 |
Legal Settlements | - | -65 | - | -267 | - | - |
Other Unusual Items | - | - | - | -25 | - | -75 |
Pretax Income | 2,942 | 3,059 | 3,956 | 3,392 | 2,660 | 3,087 |
Income Tax Expense | 779 | 798 | 907 | 937 | 693 | 749 |
Earnings From Continuing Operations | 2,163 | 2,261 | 3,049 | 2,455 | 1,967 | 2,338 |
Net Income to Company | 2,163 | 2,261 | 3,049 | 2,455 | 1,967 | 2,338 |
Minority Interest in Earnings | -125 | -129 | -160 | -155 | -182 | -172 |
Net Income | 2,038 | 2,132 | 2,889 | 2,300 | 1,785 | 2,166 |
Net Income to Common | 2,038 | 2,132 | 2,889 | 2,300 | 1,785 | 2,166 |
Net Income Growth | -29.92% | -26.20% | 25.61% | 28.85% | -17.59% | -19.63% |
Shares Outstanding (Basic) | 804 | 809 | 819 | 827 | 836 | 845 |
Shares Outstanding (Diluted) | 806 | 811 | 823 | 829 | 839 | 848 |
Shares Change | -1.49% | -1.47% | -0.72% | -1.14% | -1.12% | -1.28% |
EPS (Basic) | 2.54 | 2.64 | 3.53 | 2.78 | 2.13 | 2.56 |
EPS (Diluted) | 2.53 | 2.63 | 3.51 | 2.77 | 2.13 | 2.55 |
EPS Growth | -28.82% | -25.07% | 26.71% | 30.05% | -16.47% | -18.79% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3,858 | 3,634 | 3,546 | 3,040 | 1,860 | 2,758 |
Free Cash Flow Per Share | 4.79 | 4.48 | 4.31 | 3.67 | 2.22 | 3.25 |
Dividend Per Share | 2.090 | 2.060 | 1.980 | 1.910 | 1.860 | 1.790 |
Dividend Growth | 3.46% | 4.04% | 3.67% | 2.69% | 3.91% | 2.29% |
Gross Margin | 60.43% | 60.11% | 60.60% | 58.21% | 57.04% | 59.55% |
Operating Margin | 20.63% | 20.79% | 21.14% | 20.22% | 19.82% | 21.89% |
Profit Margin | 9.68% | 10.46% | 14.37% | 11.82% | 9.93% | 12.43% |
Free Cash Flow Margin | 18.33% | 17.83% | 17.64% | 15.62% | 10.35% | 15.83% |
EBITDA | 4,983 | 4,868 | 4,855 | 4,501 | 4,107 | 4,369 |
EBITDA Margin | 23.68% | 23.88% | 24.15% | 23.13% | 22.86% | 25.08% |
D&A For EBITDA | 642 | 630 | 605 | 567 | 545 | 556 |
EBIT | 4,341 | 4,238 | 4,250 | 3,934 | 3,562 | 3,813 |
EBIT Margin | 20.63% | 20.79% | 21.14% | 20.22% | 19.82% | 21.89% |
Effective Tax Rate | 26.48% | 26.09% | 22.93% | 27.62% | 26.05% | 24.26% |
Advertising Expenses | - | 2,703 | 2,720 | 2,371 | 1,997 | 2,021 |